Uranium Energy Corp. (UEC): UEC revenue beat expectations on inventory sales as uranium production ramped sharply sequentially, though annual output remained below Goldman Sachs estimates.

Overview

This first take assesses Uranium Energy's FY2026 and F4Q26 operating results. Goldman Sachs emphasizes an earnings-revenue beat from uranium inventory sales, a meaningful sequential production recovery, and better-than-expected costs, while noting that production still fell short of its forecasts.

Core views

UEC sold 200,000 lbs of U3O8 in F4Q26 at approximately $85.26/lb, generating $17.1mn of revenue. This was ahead of Goldman Sachs' expectation for no quarterly uranium sales and above FactSet consensus revenue of $9.0mn. For FY2026, the company sold 400,000 lbs from inventory at a weighted average price of $93.13/lb. Goldman Sachs attributes the stronger revenue outcome to the solid uranium-price environment and the company's ability to monetize inventory. Production improved substantially in F4Q26 but remained below the institution's forecast. UEC produced 82,744 lbs of precipitated uranium and dried-and-drummed U3O8 during the quarter, up more than 150% quarter on quarter but below Goldman Sachs' approximately 160,000-lb estimate. The improvement included first production of 17,352 lbs from Burke Hollow and a roughly 200% increase at Christensen Ranch to 65,392 lbs after regulatory delays had weighed on output for several quarters. Aggregate FY2026 production was 229,294 lbs, below the approximately 307,000 lbs Goldman Sachs had expected. Cost performance was better than expected. FY2026 total production costs were $39.94/lb versus Goldman Sachs' $43.50/lb estimate. F4Q26 total cost per pound fell to $36.54/lb, below the $45.00/lb estimate and down from $54.61/lb in F3Q26, reflecting improved production volumes during the quarter. Despite FY2026 inventory sales, UEC ended the year with 1.26mn lbs of U3O8 inventory, excluding 359,260 lbs of precipitated uranium and dried-and-drummed U3O8 held at processing facilities. Goldman Sachs notes that this remains a sizable inventory position and that the company is unhedged to uranium prices. Its $14 12-month price target is based on applying a 26x EV/EBITDA multiple to its F2028 EBITDA estimate and then adding net cash.

Analysis framework

Goldman Sachs compares reported uranium sales, revenue, production volumes and unit costs with its own estimates and FactSet consensus, then explains the operational drivers of sequential production changes. Its valuation applies an EV/EBITDA multiple to F2028 EBITDA estimates and adds net cash to derive the price target.

Methodology notes

• Valuation methodsEV/EBITDA valuation

  26x EV/EBITDA multiple applied to Goldman Sachs' F2028 EBITDA estimate, followed by the addition of net cash.

  Enterprise value is valued relative to projected EBITDA; adding net cash converts that enterprise value into Goldman Sachs' equity price target.

• Industry AnalysisVolume-price decomposition

  Assessment of uranium sales volumes, realized uranium prices, production volumes and unit production costs.

  The report separates the effects of pounds sold, realized U3O8 prices, production output and cost per pound to explain revenue and operating performance.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Uranium Energy Corp. (UEC)

  Primary covered company; revenue benefited from uranium inventory sales and production is ramping.

  Strengths

  F4Q26 revenue exceeded Goldman Sachs and FactSet expectations; production rebounded sequentially; unit costs were below estimates; inventory remains substantial.

  Weaknesses

  F4Q26 and FY2026 production were below Goldman Sachs forecasts.

  Comparison

  F4Q26 revenue was $17.1mn versus FactSet consensus of $9.0mn; F4Q26 production was 82,744 lbs versus Goldman Sachs' approximately 160,000-lb forecast.

  Risks

  Uranium-price volatility or weakness, uncertain production-ramp timing and pace, higher production costs, and dilution from greater liquidity needs.

Key data

• F4Q26 uranium sales200,000 lbs of U3O8 at approximately $85.26/lbGenerated $17.1mn in revenue; Goldman Sachs had expected no uranium sales.
• F4Q26 revenue$17.1mnAbove FactSet consensus of $9.0mn.
• F4Q26 production82,744 lbsUp more than 150% quarter on quarter but below Goldman Sachs' approximately 160,000-lb forecast.
• FY2026 production229,294 lbsBelow Goldman Sachs' approximately 307,000-lb forecast.
• FY2026 inventory sales400,000 lbs at a weighted average $93.13/lbSales were made from inventory.
• FY2026 production cost$39.94/lbBelow Goldman Sachs' $43.50/lb estimate.
• F4Q26 production cost$36.54/lbBelow Goldman Sachs' $45.00/lb estimate and down from $54.61/lb in F3Q26.
• Year-end U3O8 inventory1.26mn lbsExcludes 359,260 lbs held as precipitated uranium and dried-and-drummed U3O8 at processing facilities.

Impact & implications

Goldman Sachs views the revenue beat and lower costs as favorable results, while the production recovery at Burke Hollow and Christensen Ranch signals ramp progress. However, annual and quarterly production remained below its forecasts, and the company retains exposure to uranium-price movements through its sizable unhedged inventory.

Risks

• Uranium prices may remain volatile or subdued.
• The timing and pace of the production ramp remain uncertain.
• Production costs could be higher than expected.
• Greater liquidity needs could lead to continued dilution.